Coya Therapeutics, Inc. (COYA) vs NRx Pharmaceuticals, Inc. (NRXP)
A side-by-side comparison of Coya Therapeutics, Inc. and NRx Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COYA
Coya Therapeutics, Inc.
$4.85HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NRXP
NRx Pharmaceuticals, Inc.
$2.94HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — COYA vs NRXP
growth of $100 · dividends reinvested · last 4yCOYA +6.1% (+1.5%/yr)NRXP -73.9% (-28.5%/yr)COYA compounded faster over this window
COYA NRXP
COYA vs NRXP: by the numbers
- •NRXP is the larger company ($127M vs $114M market cap).
- •Both run net losses; COYA's is the smaller (-270.22% vs -691.81% net margin).
Metrics side by side
Valuation
| Metric | COYA | NRXP |
|---|---|---|
| P/S ratio | 14.19 | 37.50 |
| P/B ratio | 0.00 | N/A |
Profitability
| Metric | COYA | NRXP |
|---|---|---|
| Gross margin | 99.91% | 58.78% |
| Operating margin | -255.05% | -1324.41% |
| Net margin | -270.22% | -691.81% |
| ROE | -0.05% | N/A |
| ROIC | -0.05% | N/A |
Growth (annualized)
| Metric | COYA | NRXP |
|---|---|---|
| Total return CAGR (5Y) | N/A | -49.61% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.